nodes	percent_of_prediction	percent_of_DWPC	metapath
Methohexital—Laryngospasm—Medroxyprogesterone Acetate—uterine cancer	0.0465	0.0465	CcSEcCtD
Methohexital—Injection site pain—Medroxyprogesterone Acetate—uterine cancer	0.0425	0.0425	CcSEcCtD
Methohexital—Thrombophlebitis—Progesterone—uterine cancer	0.0321	0.0321	CcSEcCtD
Methohexital—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.0291	0.0291	CcSEcCtD
Methohexital—Laryngospasm—Etoposide—uterine cancer	0.0262	0.0262	CcSEcCtD
Methohexital—Liver function test abnormal—Progesterone—uterine cancer	0.0257	0.0257	CcSEcCtD
Methohexital—Apnoea—Etoposide—uterine cancer	0.0231	0.0231	CcSEcCtD
Methohexital—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.0214	0.0214	CcSEcCtD
Methohexital—Rhinitis—Progesterone—uterine cancer	0.0193	0.0193	CcSEcCtD
Methohexital—Liver function test abnormal—Dactinomycin—uterine cancer	0.0181	0.0181	CcSEcCtD
Methohexital—Erythema—Progesterone—uterine cancer	0.0167	0.0167	CcSEcCtD
Methohexital—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.0152	0.0152	CcSEcCtD
Methohexital—Convulsion—Progesterone—uterine cancer	0.0145	0.0145	CcSEcCtD
Methohexital—Anxiety—Progesterone—uterine cancer	0.0142	0.0142	CcSEcCtD
Methohexital—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.0139	0.0139	CcSEcCtD
Methohexital—Anaphylactic shock—Progesterone—uterine cancer	0.0137	0.0137	CcSEcCtD
Methohexital—Injection site pain—Epirubicin—uterine cancer	0.0134	0.0134	CcSEcCtD
Methohexital—Shock—Progesterone—uterine cancer	0.0134	0.0134	CcSEcCtD
Methohexital—Tachycardia—Progesterone—uterine cancer	0.0133	0.0133	CcSEcCtD
Methohexital—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.0131	0.0131	CcSEcCtD
Methohexital—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.0129	0.0129	CcSEcCtD
Methohexital—Delirium—Epirubicin—uterine cancer	0.0128	0.0128	CcSEcCtD
Methohexital—Hypotension—Progesterone—uterine cancer	0.0128	0.0128	CcSEcCtD
Methohexital—Injection site pain—Doxorubicin—uterine cancer	0.0124	0.0124	CcSEcCtD
Methohexital—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.0124	0.0124	CcSEcCtD
Methohexital—Dyspnoea—Progesterone—uterine cancer	0.0122	0.0122	CcSEcCtD
Methohexital—Shock—Medroxyprogesterone Acetate—uterine cancer	0.0122	0.0122	CcSEcCtD
Methohexital—Bronchospasm—Etoposide—uterine cancer	0.0121	0.0121	CcSEcCtD
Methohexital—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0121	0.0121	CcSEcCtD
Methohexital—Erythema—Dactinomycin—uterine cancer	0.0118	0.0118	CcSEcCtD
Methohexital—Delirium—Doxorubicin—uterine cancer	0.0118	0.0118	CcSEcCtD
Methohexital—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0116	0.0116	CcSEcCtD
Methohexital—Gastrointestinal pain—Progesterone—uterine cancer	0.0112	0.0112	CcSEcCtD
Methohexital—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.011	0.011	CcSEcCtD
Methohexital—Hiccups—Epirubicin—uterine cancer	0.011	0.011	CcSEcCtD
Methohexital—Urticaria—Progesterone—uterine cancer	0.0108	0.0108	CcSEcCtD
Methohexital—Abdominal pain—Progesterone—uterine cancer	0.0108	0.0108	CcSEcCtD
Methohexital—Salivary hypersecretion—Epirubicin—uterine cancer	0.0107	0.0107	CcSEcCtD
Methohexital—Hiccups—Doxorubicin—uterine cancer	0.0102	0.0102	CcSEcCtD
Methohexital—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0101	CcSEcCtD
Methohexital—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00986	0.00986	CcSEcCtD
Methohexital—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00983	0.00983	CcSEcCtD
Methohexital—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00978	0.00978	CcSEcCtD
Methohexital—Pruritus—Progesterone—uterine cancer	0.00966	0.00966	CcSEcCtD
Methohexital—Thrombophlebitis—Epirubicin—uterine cancer	0.0092	0.0092	CcSEcCtD
Methohexital—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00875	0.00875	CcSEcCtD
Methohexital—Vomiting—Progesterone—uterine cancer	0.00868	0.00868	CcSEcCtD
Methohexital—Headache—Progesterone—uterine cancer	0.00855	0.00855	CcSEcCtD
Methohexital—Thrombophlebitis—Doxorubicin—uterine cancer	0.00852	0.00852	CcSEcCtD
Methohexital—Nausea—Progesterone—uterine cancer	0.00811	0.00811	CcSEcCtD
Methohexital—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00789	0.00789	CcSEcCtD
Methohexital—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00787	0.00787	CcSEcCtD
Methohexital—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00775	0.00775	CcSEcCtD
Methohexital—Abdominal pain—Dactinomycin—uterine cancer	0.00763	0.00763	CcSEcCtD
Methohexital—Convulsion—Etoposide—uterine cancer	0.00742	0.00742	CcSEcCtD
Methohexital—Liver function test abnormal—Epirubicin—uterine cancer	0.00736	0.00736	CcSEcCtD
Methohexital—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00735	0.00735	CcSEcCtD
Methohexital—Anaphylactic shock—Etoposide—uterine cancer	0.00699	0.00699	CcSEcCtD
Methohexital—Tachycardia—Etoposide—uterine cancer	0.00682	0.00682	CcSEcCtD
Methohexital—Liver function test abnormal—Doxorubicin—uterine cancer	0.00681	0.00681	CcSEcCtD
Methohexital—Hypotension—Etoposide—uterine cancer	0.00653	0.00653	CcSEcCtD
Methohexital—Dyspnoea—Etoposide—uterine cancer	0.00623	0.00623	CcSEcCtD
Methohexital—Vomiting—Dactinomycin—uterine cancer	0.00614	0.00614	CcSEcCtD
Methohexital—Nausea—Dactinomycin—uterine cancer	0.00573	0.00573	CcSEcCtD
Methohexital—Gastrointestinal pain—Etoposide—uterine cancer	0.00571	0.00571	CcSEcCtD
Methohexital—Urticaria—Etoposide—uterine cancer	0.00555	0.00555	CcSEcCtD
Methohexital—Rhinitis—Epirubicin—uterine cancer	0.00553	0.00553	CcSEcCtD
Methohexital—Abdominal pain—Etoposide—uterine cancer	0.00552	0.00552	CcSEcCtD
Methohexital—Rhinitis—Doxorubicin—uterine cancer	0.00511	0.00511	CcSEcCtD
Methohexital—Pruritus—Etoposide—uterine cancer	0.00494	0.00494	CcSEcCtD
Methohexital—Erythema—Epirubicin—uterine cancer	0.0048	0.0048	CcSEcCtD
Methohexital—Vomiting—Etoposide—uterine cancer	0.00444	0.00444	CcSEcCtD
Methohexital—Erythema—Doxorubicin—uterine cancer	0.00444	0.00444	CcSEcCtD
Methohexital—Agitation—Epirubicin—uterine cancer	0.00441	0.00441	CcSEcCtD
Methohexital—Headache—Etoposide—uterine cancer	0.00438	0.00438	CcSEcCtD
Methohexital—Convulsion—Epirubicin—uterine cancer	0.00416	0.00416	CcSEcCtD
Methohexital—Nausea—Etoposide—uterine cancer	0.00415	0.00415	CcSEcCtD
Methohexital—Agitation—Doxorubicin—uterine cancer	0.00408	0.00408	CcSEcCtD
Methohexital—Anxiety—Epirubicin—uterine cancer	0.00407	0.00407	CcSEcCtD
Methohexital—Anaphylactic shock—Epirubicin—uterine cancer	0.00392	0.00392	CcSEcCtD
Methohexital—Shock—Epirubicin—uterine cancer	0.00385	0.00385	CcSEcCtD
Methohexital—Convulsion—Doxorubicin—uterine cancer	0.00385	0.00385	CcSEcCtD
Methohexital—Tachycardia—Epirubicin—uterine cancer	0.00382	0.00382	CcSEcCtD
Methohexital—Anxiety—Doxorubicin—uterine cancer	0.00377	0.00377	CcSEcCtD
Methohexital—Hypotension—Epirubicin—uterine cancer	0.00366	0.00366	CcSEcCtD
Methohexital—Anaphylactic shock—Doxorubicin—uterine cancer	0.00362	0.00362	CcSEcCtD
Methohexital—Shock—Doxorubicin—uterine cancer	0.00356	0.00356	CcSEcCtD
Methohexital—Tachycardia—Doxorubicin—uterine cancer	0.00354	0.00354	CcSEcCtD
Methohexital—Dyspnoea—Epirubicin—uterine cancer	0.00349	0.00349	CcSEcCtD
Methohexital—Hypotension—Doxorubicin—uterine cancer	0.00339	0.00339	CcSEcCtD
Methohexital—Dyspnoea—Doxorubicin—uterine cancer	0.00323	0.00323	CcSEcCtD
Methohexital—Gastrointestinal pain—Epirubicin—uterine cancer	0.0032	0.0032	CcSEcCtD
Methohexital—Urticaria—Epirubicin—uterine cancer	0.00311	0.00311	CcSEcCtD
Methohexital—Abdominal pain—Epirubicin—uterine cancer	0.0031	0.0031	CcSEcCtD
Methohexital—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00296	0.00296	CcSEcCtD
Methohexital—Urticaria—Doxorubicin—uterine cancer	0.00288	0.00288	CcSEcCtD
Methohexital—Abdominal pain—Doxorubicin—uterine cancer	0.00286	0.00286	CcSEcCtD
Methohexital—Pruritus—Epirubicin—uterine cancer	0.00277	0.00277	CcSEcCtD
Methohexital—Pruritus—Doxorubicin—uterine cancer	0.00256	0.00256	CcSEcCtD
Methohexital—Vomiting—Epirubicin—uterine cancer	0.00249	0.00249	CcSEcCtD
Methohexital—Headache—Epirubicin—uterine cancer	0.00245	0.00245	CcSEcCtD
Methohexital—Nausea—Epirubicin—uterine cancer	0.00233	0.00233	CcSEcCtD
Methohexital—Vomiting—Doxorubicin—uterine cancer	0.0023	0.0023	CcSEcCtD
Methohexital—Headache—Doxorubicin—uterine cancer	0.00227	0.00227	CcSEcCtD
Methohexital—Nausea—Doxorubicin—uterine cancer	0.00215	0.00215	CcSEcCtD
